Integrated Development Associates

Tokyo, Japan Founded: 2004 • Age: 22 yrs Acquired By Chiltern International
Full-service CRO, based out of Japan and Asia and also offering regulatory consulting services

About Integrated Development Associates

Integrated Development Associates is a Healthcare company based in Tokyo (Japan) founded in 2004, and was acquired by Chiltern International in May 2017. Full-service CRO, based out of Japan and Asia and also offering regulatory consulting services. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service.

Company details

Integrated Development Associates (IDA), acquired by Chiltern in May, 2017, is a full-service CRO also specialising in providing product development and regulatory consulting services mainly for new biopharmaceutical products in Japan and Asia. Their key service offerings include development of the market entry strategy (medical and scientific analysis, product positioning in Japan), regulatory services (KOL interactions, PMDA interactions), comprehensive clinical development services (turnkey Phase 1 and Phase 2-4 implementation), Clinical Trial In-Country Caretaker (CT-ICC) services for Japanese clinical trial conduct, and filing and maintenance of official submissions to MHLW on behalf of clients. The company claims to be one of the 5 companies to have received SAKIGAKE Designation (breakthrough therapy) from the Japanese authorities. IDA has experience in a wide range of therapeutic areas including CNS, metabolic, cardiovascular and infectious diseases, oncology (almost all types) and orphan diseases. They also have experience in developing cell therapies and regenerative medicine.

  • Headquarters Tokyo, Japan
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website i-d-a.com
  • Social LinkedIn Facebook
  • Acquired by Chiltern International (May 2017)
Key Metrics

Investors in Integrated Development Associates

Integrated Development Associates has secured backing from 1 investor. Prominent investors backing the company include Chiltern International.

All
InvestorDescriptionFounded YearDomainLocation
Full service CRO with expertise in oncology related development services
1982chiltern.comBerkshire County, United States
Premium access

Investor details for Integrated Development Associates

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Integrated Development Associates

2 dated milestones of Integrated Development Associates across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded Integrated Development Associates is founded.
  2. Exit Acquired by Chiltern International.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Integrated Development Associates

Integrated Development Associates was founded in 2004.

Integrated Development Associates is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.

Integrated Development Associates (IDA), acquired by Chiltern in May, 2017, is a full-service CRO also specialising in providing product development and regulatory consulting services mainly for new biopharmaceutical products in Japan and Asia. Their key service offerings include development of the market entry strategy (medical and scientific analysis, product positioning in Japan), regulatory services (KOL interactions, PMDA interactions), comprehensive clinical development services (turnkey Phase 1 and Phase 2-4 implementation), Clinical Trial In-Country Caretaker (CT-ICC) services for Japanese clinical trial conduct, and filing and maintenance of official submissions to MHLW on behalf of clients. The company claims to be one of the 5 companies to have received SAKIGAKE Designation (breakthrough therapy) from the Japanese authorities. IDA has experience in a wide range of therapeutic areas including CNS, metabolic, cardiovascular and infectious diseases, oncology (almost all types) and orphan diseases. They also have experience in developing cell therapies and regenerative medicine.

Integrated Development Associates has 1 investor. Key investors include Chiltern International.

Yes. Integrated Development Associates was acquired by Chiltern International in May 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available